Curevac logo

Curevac Share Price (NASDAQ: CVAC)

$5.38

0.01

(0.19%)

Last updated on

Check the interactive Curevac Stock chart to analyse performance

Curevac stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$5.36
    Today's High:$5.39

    Day's Volatility :0.56%

  • 52 Weeks Low:$2.37
    52 Weeks High:$5.72

    52 Weeks Volatility :58.57%

Curevac Stock Returns

PeriodCurevacSector (Health Care)Index (Russel 2000)
3 Months
16.31%
3.6%
0.0%
6 Months
74.84%
-7.7%
0.0%
1 Year
75.98%
-12.6%
0.0%
3 Years
-46.31%
9.5%
-4.7%

Curevac Key Stats

Check Curevac key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$5.37
Open
$5.37
Today's High
$5.39
Today's Low
$5.36
Market Capitalization
$1.2B
Today's Volume
$321.2K
52 Week High
$5.72
52 Week Low
$2.37
Revenue TTM
$510.5M
EBITDA
$248.7M
Earnings Per Share (EPS)
$1.0
PE Ratio
5.37
Profit Margin
37.93%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
40.22%

Stock Returns calculator for Curevac Stock including INR - Dollar returns

The Curevac stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Curevac investment value today

Current value as on today

₹1,81,101

Returns

₹81,101

(+81.1%)

Returns from Curevac Stock

₹75,817 (+75.82%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Curevac Stock

-29%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Curevac Stock from India on INDmoney has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Curevac

  • Name

    Holdings %

  • Eckert Corp

    0.88%

  • Millennium Management LLC

    0.81%

  • Qube Research & Technologies

    0.53%

  • BlackRock Inc

    0.49%

  • Water Island Capital LLC

    0.43%

  • UBS Group AG

    0.37%

Analyst Recommendation on Curevac Stock

Rating
Trend

Buy

    66%Buy

    26%Hold

    6%Sell

Based on 15 Wall street analysts offering stock ratings for Curevac(by analysts ranked 0 to 5 stars)

Curevac Share Price Target

What analysts predicted

Downside of 0.35%

Target:

$5.36

Current:

$5.38

Curevac share price target is $5.36, a slight Downside of 0.35% compared to current price of $5.38 as per analysts' prediction.

Curevac Stock Insights

  • Price Movement

    In the last 6 months, CVAC stock has moved up by 73.7%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 893.0K → 1.24M (in $), with an average increase of 28.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, 338.04M → -59.56M (in $), with an average decrease of 61.0% per quarter
  • CVAC vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 160.0%

Curevac Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$559.9M
↑ 895.54%
Net Income
$169.7M
↓ 162.34%
Net Profit Margin
30.3%
↑ 514.26%

Curevac Technicals Summary

Sell

Neutral

Buy

Curevac is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Curevac Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Curevac logo
-0.09%
74.84%
75.98%
-46.31%
-90.53%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Curevac

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company's portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy. It also delivers optimized mRNAs to stimulate the production of therapeutic proteins utilizing its technology and instructs human cells to produce or secrete specific proteins in the nucleus, cytoplasm, cellular organelles, and cell membrane. In addition, the company offers The RNA Printer, a downsized, integrated, and highly automated process for manufacturing of mRNA vaccines and therapeutics. Further, it develops prophylactic vaccine lead candidate that addresses urinary tract infections targeting uropathogenic E. coli (UPEC) bacteria; vaccine candidates CV0601 and CV0701, which are in phase 2 clinical study against SARS-CoV-2; vaccines for off-the-shelf and fully personalized cancer precision immunotherapies in oncology; and CVGBM for treating cancer. Additionally, the company develops, manufactures, and commercializes mRNA vaccines targeting SARS-CoV-2 variants; antigen cancer precision immunotherapy candidate that targets squamous non-small cell lung cancer; and antigen cancer precision immunotherapy candidate CVGBM that is tested in patients with surgically resected MGMT-unmethylated glioblastoma or astrocytoma with a molecular signature of glioblastoma. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.
Organization
Curevac
Employees
825
CEO
Dr. Alexander Zehnder M.B.A., M.D.
Industry
Health Technology

Key Management of Curevac

NameTitle
Dr. Alexander Zehnder M.B.A., M.D.
CEO, MD & Member of Management Board
Mr. Axel-Sven Malkomes
CFO & Member of Executive Board
Dr. Malte Greune Ph.D.
COO, Member of Management Board & MD
Dr. Myriam Mendila M.D.
Chief Scientific Officer, Head of R&D, MD & Member of the Management Board
Mr. Thaminda Ramanayake
Chief Business Officer & Member of Executive Board
Dr. Sarah Fakih
Vice President of Corporate Communications & Investor Relations
Mr. Marco Rau L.L.M., Ph.D.
General Counsel
Slavica Stevanovic-Heck
Head of Human Resources
Dr. Ulrike Gnad-Vogt M.D., Ph.D.
Senior VP & Area Head of Oncology
Dr. Patrick Baumhof
Senior Vice President of Technology

Important FAQs about investing in CVAC Stock from India :

What is Curevac share price today?

Curevac share price today is $5.38 as on at the close of the market. Curevac share today touched a day high of $5.39 and a low of $5.36.

What is the 52 week high and 52 week low for Curevac share?

Curevac share touched a 52 week high of $5.72 and a 52 week low of $2.37. Curevac stock price today i.e. is closed at $5.38, lower by 5.94% versus the 52 week high.

How to invest in Curevac Stock (CVAC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Curevac on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Curevac Shares that will get you 0.2788 shares as per Curevac share price of $5.38 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Curevac Stock (CVAC) from India?

Indian investors can start investing in Curevac (CVAC) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Curevac stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Curevac share’s latest price of $5.38 as on August 30, 2025 at 1:29 am IST, you will get 1.8587 shares of Curevac. Learn more about fractional shares .

What are the returns that Curevac has given to Indian investors in the last 5 years?

Curevac stock has given -90.53% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?